<--- Back to Details
First PageDocument Content
Transplantation medicine / Myeloid leukemia / Acute leukemia / Cell biology / National Marrow Donor Program / Hematopoietic stem cell transplantation / Cord blood / Myelodysplastic syndrome / Acute myeloid leukemia / Medicine / Biology / Stem cells
Date: 2012-08-19 23:24:27
Transplantation medicine
Myeloid leukemia
Acute leukemia
Cell biology
National Marrow Donor Program
Hematopoietic stem cell transplantation
Cord blood
Myelodysplastic syndrome
Acute myeloid leukemia
Medicine
Biology
Stem cells

 Helpful information for patients, caregivers and families Bone Marrow/Stem Cell Transplant Frequently Asked Questions

Add to Reading List

Source URL: www.nbmtlink.org

Download Document from Source Website

File Size: 4,22 MB

Share Document on Facebook

Similar Documents

Lifebank_Logo_withTag-centered

Lifebank_Logo_withTag-centered

DocID: 1rakV - View Document

NIH Public Access Author Manuscript Clin Lymphoma Myeloma. Author manuscript; available in PMC 2009 November 30. NIH-PA Author Manuscript

NIH Public Access Author Manuscript Clin Lymphoma Myeloma. Author manuscript; available in PMC 2009 November 30. NIH-PA Author Manuscript

DocID: 1qxR7 - View Document

Microsoft Word - blood_cancer_gene_sanger_institute_release

Microsoft Word - blood_cancer_gene_sanger_institute_release

DocID: 1qeRh - View Document

Needham & Company 15th Annual Healthcare Conference John Scarlett, M.D. President & CEO, Geron Corporation April 12, 2016

Needham & Company 15th Annual Healthcare Conference John Scarlett, M.D. President & CEO, Geron Corporation April 12, 2016

DocID: 1pn6V - View Document

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES www.mjhid.org ISSNOriginal Article Clinical Analysis and Optimization of Postremission Therapy for Acute Myeloid Leukemia Patients with Minimal Resid

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES www.mjhid.org ISSNOriginal Article Clinical Analysis and Optimization of Postremission Therapy for Acute Myeloid Leukemia Patients with Minimal Resid

DocID: 1oCtU - View Document